FeesSafety
Pluang+

JP Morgan affirms 'overweight' rating on Computacenter, citing record order visibility and growth through 2028

Analyst Insights
20 Nov 2026, 02:15 WIB
Proactive Investors
View Source
Bullish
JP Morgan affirms 'overweight' rating on Computacenter, citing record order visibility and growth through 2028

JP Morgan maintains an 'overweight' rating on Computacenter after positive discussions with management about growth prospects through 2027 and 2028. The IT services provider shows record near-term order visibility and expanding order books, supported by sustained investment in technology infrastructure. Regional gains in the UK and expected improvement in Germany bolster confidence, while France remains a focus for turnaround efforts. JP Morgan highlights Computacenter's competitive edge serving infrastructure-heavy clients and anticipates insights from the upcoming capital markets day.

Computacenter's growth outlook is the subject, with Pluang's Technology sector market data providing context. For readers following Technology stocks, here is Pluang's market snapshot as of Nov 20, 2026 06:11 WIB: out of 150 priced US Technology stocks, 13 rose and 137 fell. Notable movers include VERI (Veritone Inc) at USD 0.38 with a 1-day change of +9.32% and 100% buy order activity, ESTC (Elastic NV) at USD 75.48 down 9.07%, and EGHT (8x8 Inc) at USD 1.97 down 8.80% with 100% sell order activity. The most notable figure is the 137 stocks that fell today.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App